Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer
- Citation:
- JAMA vol 325 (13) 1277-1285
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 3228
- Children:
- None
- Pharmas:
- Pfizer
- Grants:
- U10CA180821, U10CA180882, U10CA180794, UG1CA233163, UG1CA233253, UG1CA233290, UG1CA233320, UG1CA233337, UG1CA233339, UG1CA189954, U10CA180863 (CCTG); UG1CA233196, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Jeffrey A. Meyerhardt Qian Shi Charles S. Fuchs Jeffrey Meyer Donna Niedzwiecki Tyler Zemla Priya Kumthekar Katherine A. Guthrie Felix Couture Philip Kuebler Johanna C. Bendell Pankaj Kumar Dequincy Lewis Benjamin Tan Monica Bertagnolli Axel Grothey Howard S. Hochster Richard M. Goldberg Alan Venook Charles Blanke Eileen M. O'Reilly Anthony F. Shields
- Networks:
- CA824, HEARTLAND, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, OR013, SCOR
- Study
- Alliance-A151939
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- N/A, 3
- Keywords:
- Research, Research, Original Investigation